This inventor holds 1 USPTO granted patent. Top assignee: Msd K.k.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Katsuya Ohbuchi: Innovator in Gene Modification
Introduction
Katsuya Ohbuchi is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of genetic engineering, particularly in the study of lipid metabolism. His innovative work has led to the development of gene-modified non-human animals, which are crucial for understanding the functions of specific genes in vivo.
Latest Patents
Katsuya Ohbuchi holds a patent for an animal having a modification in the MGAT2 gene. This patent aims to provide a gene-modified non-human animal with an inactivated MGAT2 gene, which is essential for researching the gene's function. Additionally, it outlines methods for screening compounds that can inhibit the activity of MGAT2. This research is vital for detecting diseases induced by abnormal lipid metabolism, offering potential pathways for prevention and treatment.
Career Highlights
Katsuya Ohbuchi is associated with MSD K.K., where he continues to advance his research in genetic modifications. His work has garnered attention for its potential applications in medical science, particularly in understanding and treating metabolic disorders.
Collaborations
Katsuya collaborates with notable colleagues, including Naomi Murai and Naomoto Harada. Their combined expertise enhances the research efforts in gene modification and its implications for health.
Conclusion
Katsuya Ohbuchi's innovative contributions to genetic engineering, particularly through his patent on the MGAT2 gene, highlight his role as a key figure in advancing medical research. His work not only furthers scientific understanding but also opens new avenues for treating diseases related to lipid metabolism.